Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baloxavir vs Oseltamivir in Children 6–11 Years With Influenza
jRCTs011200011Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of baloxavir marboxil in influenza (2 arms), sponsored by Shionogi & Co., Ltd. Primary endpoint: Time to alleviation of influenza symptoms. Started Jan 2023; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on jRCTs011200011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011200011.